- Home
- PPTA vs ARQT Comparison
PPTA vs ARQT Comparison
Compare PPTA & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPTA
- ARQT
- Stock Information
- Founded
- PPTA 2011
- ARQT 2016
- Country
- PPTA United States
- ARQT United States
- Employees
- PPTA N/A
- ARQT N/A
- Industry
- PPTA Precious Metals
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- PPTA Basic Materials
- ARQT Health Care
- Exchange
- PPTA Nasdaq
- ARQT Nasdaq
- Market Cap
- PPTA 2.9B
- ARQT 3.3B
- IPO Year
- PPTA N/A
- ARQT 2020
- Fundamental
- Price
- PPTA $25.01
- ARQT $30.97
- Analyst Decision
- PPTA Strong Buy
- ARQT Strong Buy
- Analyst Count
- PPTA 4
- ARQT 7
- Target Price
- PPTA $25.38
- ARQT $22.17
- AVG Volume (30 Days)
- PPTA 3.0M
- ARQT 2.7M
- Earning Date
- PPTA 11-17-2025
- ARQT 10-28-2025
- Dividend Yield
- PPTA N/A
- ARQT N/A
- EPS Growth
- PPTA N/A
- ARQT N/A
- EPS
- PPTA N/A
- ARQT N/A
- Revenue
- PPTA N/A
- ARQT $317,929,000.00
- Revenue This Year
- PPTA N/A
- ARQT $85.27
- Revenue Next Year
- PPTA N/A
- ARQT $30.70
- P/E Ratio
- PPTA N/A
- ARQT N/A
- Revenue Growth
- PPTA N/A
- ARQT 129.21
- 52 Week Low
- PPTA $7.81
- ARQT $10.57
- 52 Week High
- PPTA $31.65
- ARQT $31.11
- Technical
- Relative Strength Index (RSI)
- PPTA 58.45
- ARQT 75.88
- Support Level
- PPTA $21.00
- ARQT $27.08
- Resistance Level
- PPTA $25.24
- ARQT $31.10
- Average True Range (ATR)
- PPTA 1.67
- ARQT 1.59
- MACD
- PPTA 0.19
- ARQT 0.50
- Stochastic Oscillator
- PPTA 94.86
- ARQT 98.36
About PPTA Perpetua Resources Corp.
Perpetua Resources Corp is focused on the exploration, site restoration, and redevelopment of gold-antimony-silver deposits in the Stibnite-Yellow Pine district of central Idaho that are encompassed by the Stibnite Gold Project. The Project is one of the highest-grade, open-pit gold deposits in the United States and is designed to apply a modern, responsible mining approach to restore an abandoned mine site and produce both gold and the only mined source of antimony in the United States. It has one segment, mineral exploration in the United States.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.